*May 2020* The first lung cancer patient to be treated with a new type of immunotherapy involving the re-engineering of
*May 2020* In this video, Dr. Carbone discusses acquired resistance to osimertinib in NSCLC.
*May 2020* The study results indicated clinical efficacy against central nervous system metastases in a cohort of patients. Almonertinib also displayed
*June 2020* Webcast: Join the EGFR Registers and top lung cancer specialists discuss facts vs myths in lung cancer treatment.
*June 2020* Webcast: Listen to top experts in lung cancer discuss and interpret the latest research from ASCO 2020 with
*March 2020* A biopsy sample of tissue often is tested for specific genetic variations (also referred to as mutations) that may
*March 2020* Checkpoint inhibitors and next-generation TKIs have demonstrated improved survival outcomes in patients with non–small cell lung cancer (NSCLC);
*March 2020* Targeted sequencing of patients with acquired resistance to third-generation EGFR tyrosine kinase inhibitors (TKIs) for EGFR T790M-mutant non-small
*February 2020* Ravi Salgia, MD, PhD, is the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology and the associate
*March 2020* The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for JNJ-6372 to Janssen Pharmaceutical, a